Status: current, Defined. Date: 31-Mar 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4528701000168114 | Marcain Spinal (bupivacaine hydrochloride 20 mg / 4 mL) intrathecal injection, 5 x 4 mL ampoules (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4528711000168112 | Marcain Spinal 0.5% (20 mg/4 mL) intrathecal injection, 5 x 4 mL ampoules | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Marcain Spinal 0.5% (20 mg/4 mL) intrathecal injection, 5 x 4 mL ampoules | Is a | bupivacaine hydrochloride 0.5% (20 mg/4 mL) intrathecal injection, 5 x 4 mL ampoules | true | Inferred relationship | Some | ||
| Marcain Spinal 0.5% (20 mg/4 mL) intrathecal injection, 5 x 4 mL ampoules | Is a | trade product pack | true | Inferred relationship | Some | ||
| Marcain Spinal 0.5% (20 mg/4 mL) intrathecal injection, 5 x 4 mL ampoules | has TP | Marcain Spinal | true | Inferred relationship | Some | ||
| Marcain Spinal 0.5% (20 mg/4 mL) intrathecal injection, 5 x 4 mL ampoules | has TPUU | Marcain Spinal 0.5% (20 mg/4 mL) intrathecal injection, 4 mL ampoule | true | Inferred relationship | Some | 63981239 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Marcain Spinal 0.5% (20 mg/4 mL) intrathecal injection, 5 x 4 mL ampoules | Is a | True | Marcain Spinal 0.5% (20 mg/4 mL) intrathecal injection, 5 x 4 mL ampoules | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR